DEL-1-Regulated Immune Plasticity and Inflammatory Disorders

Area of Science:

• Immunology
• Tissue homeostasis
• Inflammation regulation

Background:

• Traditional immunology focuses on immune cells, overlooking tissue roles.
• Emerging evidence highlights tissues' active 'regulatory say' in host immunity.
• Tissue-derived molecules are crucial for understanding organ-specific immune regulation.

Purpose of the Study:

• To synthesize evidence on developmental endothelial locus-1 (DEL-1) as a tissue-derived immune regulator.
• To explore DEL-1's role in immune plasticity and inflammatory disorders.
• To discuss DEL-1's potential as a therapeutic agent.

Main Methods:

• Review of recent scientific literature on DEL-1.
• Analysis of DEL-1's interactions with integrins and phospholipids.
• Examination of DEL-1's diverse functions in different inflammatory contexts.

Main Results:

• DEL-1 regulates multiple stages of the inflammatory response, including myelopoiesis, leukocyte recruitment, efferocytosis, and inflammation resolution.
• DEL-1 acts as a local regulatory factor, demonstrating tissue immune plasticity.
• Evidence links DEL-1 to inflammatory conditions like periodontitis, multiple sclerosis, and pulmonary disorders.

Conclusions:

• DEL-1 is a critical tissue-derived molecule with broad immunoregulatory functions.
• Understanding DEL-1's role advances the concept of tissue immune plasticity.
• DEL-1 presents a promising therapeutic target for inflammatory diseases.